胰高血糖素样肽-1受体激动剂对糖耐量减低大鼠胰岛β细胞胰腺十二指肠同源盒因子-1的影响
摘要
糖耐量减低(IGT)是2型糖尿病(T2DM)患者的必经阶段,近20年来T2DM呈迅猛发展,Yang等[1]研究显示,城市、乡镇和富裕农村20岁以上人群中糖调节受损的患者达15.5%,平均每年有10%~15%的发展为糖尿病。
出处
《中国药物与临床》
CAS
2011年第4期400-402,I0001,共4页
Chinese Remedies & Clinics
参考文献9
-
1Yang W,Lu J,Jia W,et al. Prevalence of diabetes among men and women in China. N Engl J Med,2010,362( 12):1090-1101.
-
2李军,李秀钧,张杰,罗梅,周桥,赵桂芝.糖耐量受损大鼠胰岛α细胞胰高血糖素及神经肽Y的表达[J].中华内分泌代谢杂志,2004,20(3):185-189. 被引量:31
-
3De Koning EJ,Bonner-Weir S,Rabelink TJ. Preservation of β- cell function by targeting β-cell mass.Trends Pharmacol Sci, 2008,29 : 218-227.
-
4王川,严励,杨川,傅祖植,程桦.胰高糖素样肽1长期作用对RIN-m细胞胰岛素分泌功能的影响[J].中华内分泌代谢杂志,2006,22(1):75-76. 被引量:9
-
5Li Y,Cao X,Li LX,et al. β-Cell PDX-1 expression is essential for the glucoregulatory,proliferative and cytoprotective actions of glucagon-like peptide- 1. Diabetes, 2005,54(2) : 482-491.
-
6Abraham EJ,Leech CA,Lin JC,et al. Insulinotropic hormone glucagon-like peptide-1 differentition of human pancreatic isletderived progenitor cells intoinsulin-producing cells. Endocrinology, 2002,143 : 3152-3161.
-
7Sharma A,Zangen DH,Reitz P,et al. The homeodomain protein IDX-1 increases after on early burst of proliferation during pancreatic regeneration. Diabetes, 1999,48 (3) : 507-513.
-
8Noguchi H,Kaneto H,Weir GC,et al. PDX-1 protein containing its owantennapedia-like protein transduction domain can transduce pancreatic duct and islet cell. Diabetes,2003,52:1732- 1737.
-
9Keller DM, McWeeney S,Arsenlis A,et al. Characterization of pancreatic transcription factor PDX-1 binding sites using promoter microarray and serialanalysis of chromatin occupancy. J Biol Chem, 2007,282(44) : 32084-32092.
二级参考文献19
-
1杨川,程桦,王川,黎锋,魏菁.胰高血糖素样肽1诱导小鼠胚胎干细胞E14分化为胰岛素表达细胞[J].中华内分泌代谢杂志,2004,20(3):263-264. 被引量:7
-
2巩秋红,娄晋宁,叶丽亚,李光伟.重组人胰高血糖素样肽1(7-36)促进INS-1细胞胰岛素释放与合成[J].中华内分泌代谢杂志,2004,20(6):559-560. 被引量:11
-
3Kisanuki K, Kishikawa H, Araki E, et al. Expression of insulin receptor on clonal pancreatic alpha cell and its possible role for insulin-stimulated negative regulation of glucagons secretion. Diabetologia, 1995,38:422-429.
-
4Kaneko K, Shirotani T, Araki E, et al. Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells. Diabetes Res Clin Pract, 1999,44:83-89.
-
5IPP E. Impaired glucose tolerance: the irrepressible A-cell? Diabetes Care, 2000,23:569-570.
-
6Larsson H, Ahrén B. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care, 2000,23:650-657.
-
7Borghi VC, Wajchenberg BL, Cesar FP. Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance. Metabolism, 1984,33:1068-1074.
-
8Storlien LH, James DE, Burleigh KM, et al. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure and obesity in the rat. Am J Physiol, 1986,251:E576-E583.
-
9Storlin LH, Higgins JA, Thomas TC, et al. Diet composition and insulin action in animal models. Br J Nutr, 2000,83( Suppl 1): S85-S90.
-
10Reed MJ, Meszaros K, Entes LJ, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism, 2000,49:1390-1394.
共引文献38
-
1赵家伟,李秀钧.胰岛细胞胰岛素抵抗:2型糖尿病发病机制的主角?[J].中华内分泌代谢杂志,2004,20(3):183-184. 被引量:24
-
2赵铁耘,李秀钧.糖尿病诊治研究新理念[J].中国实用内科杂志,2005,25(4):302-304. 被引量:46
-
3邹效漫,马芳玲,陆菊明,潘长玉.格列美脲与格列本脲影响KK-Ay小鼠下丘脑神经肽Y分泌的比较研究[J].中华内分泌代谢杂志,2005,21(2):167-168. 被引量:2
-
4罗梅,李秀钧,李军,赵桂芝,张杰,周桥.糖尿病大鼠胰岛α细胞胰岛素受体分布和含量的初步研究[J].中华糖尿病杂志(1006-6187),2005,13(3):196-198. 被引量:6
-
5邬云红,李秀钧,李宏亮,王煜,张玄娥,柯柳,张祥迅.高脂饮食肥胖大鼠胰岛细胞胰岛素抵抗机理的探讨[J].中华医学杂志,2005,85(27):1907-1910. 被引量:56
-
6冯海英,丁焕然,史视明.2型糖尿病患者胰岛素抵抗与胰高血糖素的关系[J].中国综合临床,2006,22(8):707-708. 被引量:7
-
7张贝,袁莉,曹玲玲,邱海燕,唐兆生.长期高脂饲养大鼠胰岛形态功能改变与外周胰岛素抵抗的关系[J].中华内分泌代谢杂志,2006,22(5):467-471. 被引量:11
-
8武艳丽,赵宝珍,郗光霞,高春华.糖耐量受损Wistar大鼠模型的实验研究[J].中国药物与临床,2007,7(4):281-283. 被引量:3
-
9黄秋霞,卫衬兴,孙庆凯,杜巍.胰岛素强化治疗对2型糖尿病患者胰高血糖素、胰岛素水平的影响[J].现代医院,2008,8(1):16-17. 被引量:1
-
10黄秋霞,孙庆凯,杜巍,刘玉华,张秀薇,陈丹,孙晓玲,莫桂英.胰岛素泵治疗对初诊2型糖尿病患者胰岛细胞功能的影响[J].广东医学,2008,29(2):175-176. 被引量:5
-
1冯波.肠促胰岛素相关药物的不良反应[J].上海医药,2013,34(7):15-18.
-
2李艳娇,左玉慧,张四喜,宋燕青.治疗成人2型糖尿病的新药-阿必鲁肽[J].实用药物与临床,2015,18(10):1249-1252. 被引量:4
-
3吴霞.基于肠促胰岛素的抗糖尿病药物发展概况[J].上海医药,2013,34(7):3-6. 被引量:1
-
4医海拾贝[J].中华内科杂志,2013,52(5):446-446.
-
5何春燕.基于肠促胰岛素的抗糖尿病药物市场概况[J].上海医药,2013,34(7):60-61.
-
6黄震浩,段俊丽,王一尘.胰高血糖素样肽-1及其在心血管疾病中的作用[J].国际老年医学杂志,2011,32(2):62-66. 被引量:1
-
7王兴纯,曲伸.胰高血糖素样肽-1受体激动剂与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2014,34(1):40-42. 被引量:1
-
8盖克克,段蓉,李正翔.胰高血糖素样肽-1受体激动剂和二肽基肽酶-4抑制剂联用二甲双胍治疗2型糖尿病的疗效与安全性对比的系统评价[J].中国医院药学杂志,2017,37(7):633-638. 被引量:42
-
9黄新梅,刘军.肠促胰岛素相关药物的临床作用研究进展[J].上海医药,2013,34(7):7-10. 被引量:4
-
10彭文星,石秀锦,林阳.胰高血糖素样肽-1受体激动剂的药物相互作用[J].药品评价,2015,12(17):29-33. 被引量:1